See All Slides - tctmd.com

Slides

Presentation TCT 2012

Is Myocardial Infarction a Reasonable or Relevant Endpoint to Assess Carotid Intervention and Stroke Prevention Therapies in Clinical Practice and Trials?

Presenter: Carlos Mena

October 22, 2012

Presentation TCT 2012

CAS Following CREST: Now That the Noise Has Settled, What Is the Role of the Therapy?

Presenter: Herbert Aronow

October 22, 2012

Presentation TCT 2012

Role of Renal Revascularization in 2012 and Predictions for the Future

Presenter: Michael Jaff

October 22, 2012

Presentation TCT 2012

Lessons from the Quality-of-Life Studies in Inoperable and High-Risk Patients

Presenter: David Cohen

October 22, 2012

Presentation TCT 2012

SYNTAX Five-Year Results: Left Main Cohort

Presenter: Ted Feldman

October 22, 2012

Presentation TCT 2012

Diagnostic Testing of, Indications for, and Endovascular Approaches to Venous Obstruction in the Pelvis

Presenter: Raghu Kolluri

October 22, 2012

Presentation TCT 2012

Follow-up: Nuances of Unblinded vs. Blinded Follow-up Procedures

Presenter: David Kong

October 22, 2012

Presentation TCT 2012

A Modern Algorithm for Non-Invasive Testing Following Lower Extremity Vascular Stenting

Presenter: Michael Jaff

October 22, 2012

Presentation TCT 2012

Screening and Enrollment

Presenter: Alaide Chieffo

October 22, 2012

Presentation TCT 2012

Heart Team Logistics and Patient Selection

Presenter: Nicholas Lembo

October 22, 2012

Advertisement

Slides

Is Myocardial Infarction a Reasonable or Relevant Endpoint to Assess Carotid Intervention and Stroke Prevention Therapies in Clinical Practice and Trials?

CAS Following CREST: Now That the Noise Has Settled, What Is the Role of the Therapy?

Role of Renal Revascularization in 2012 and Predictions for the Future

Lessons from the Quality-of-Life Studies in Inoperable and High-Risk Patients

SYNTAX Five-Year Results: Left Main Cohort

Diagnostic Testing of, Indications for, and Endovascular Approaches to Venous Obstruction in the Pelvis

Follow-up: Nuances of Unblinded vs. Blinded Follow-up Procedures

A Modern Algorithm for Non-Invasive Testing Following Lower Extremity Vascular Stenting

Screening and Enrollment

Heart Team Logistics and Patient Selection

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content